AI
CVS icon

Analytic Investors’s CVS Health CVS Stock Holding History

Analytic Investors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,404
Closed -$1.02M – 621
2015
Q4 		$1.02M Buy
10,404
+4,967
+91% +$486K 0.01% 391
2015
Q3 		$524K Sell
5,437
-113,447
-95% -$11.9M 0.01% 448
2015
Q2 		$12.5M Sell
118,884
-102,756
-46% -$10.5M 0.18% 116
2015
Q1 		$22.9M Sell
221,640
-83,861
-27% -$8.49M 0.31% 85
2014
Q4 		$29.4M Sell
305,501
-38,079
-11% -$3.36M 0.42% 71
2014
Q3 		$27.3M Buy
343,580
+12,390
+4% +$977K 0.39% 79
2014
Q2 		$25M Sell
331,190
-46,670
-12% -$3.53M 0.4% 74
2014
Q1 		$28.3M Buy
377,860
+6,580
+2% +$465K 0.43% 65
2013
Q4 		$26.6M Sell
371,280
-139,956
-27% -$8.99M 0.44% 68
2013
Q3 		$29M Buy
511,236
+401,636
+366% +$23.9M 0.47% 68
2013
Q2 		$6.27M Buy
+109,600
New +$6.35M 0.1% 184

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Analytic Investors's CVS Position: Q1 2016 in Review

Analytic Investors sold out of CVS Health (CVS) in Q1 2016, closing a stake of 10,404 shares — an estimated $1.02M sold.

Analytic Investors first reported a position in CVS in Q2 2013 and held it in 11 quarters. The position peaked at $29.4M in Q4 2014. 1,562 funds tracked by Wall St. Rank hold CVS as of Q1 2016.

  • Analytic Investors reported no remaining CVS Health position as of Q1 2016 after selling out during the quarter.
  • Analytic Investors sold 10,404 CVS Health shares in Q1 2016, an estimated $1.02M.
  • Analytic Investors first reported a position in CVS Health in Q2 2013 and held it in 11 quarters.
  • Analytic Investors's CVS Health position peaked at $29.4M in Q4 2014.
  • 1,562 funds tracked by Wall St. Rank held CVS Health as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.